
Tasyca Pharma Private Limited
About Tasyca Pharma Private Limited
Data last updated:
Tasyca Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2013PTC071840. Its GSTIN is 29AAECT8229K1ZR (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Adarsh Narasimha Murthy and Anasuya Narsimha Murthy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thammaiah #15/3/2A 80 Feet Ring Road Nagadevanahalli, Bangalore, Karnataka, India – 560056.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.52 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹3.19 Lakh (net margin -12.5%) and EBITDA of -₹3.13 Lakh (EBITDA margin -12.3%). Revenue has grown at a compounded annual rate (CAGR) of 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tasyca Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressThammaiah #15/3/2A 80 Feet Ring Road Nagadevanahalli, Bangalore, Karnataka, India – 560056
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Tasyca Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Tasyca Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tasyca Pharma Private Limited, buy the company report.
Financials of Tasyca Pharma Private Limited
FY 2025 filings availableTasyca Pharma Private Limited reported revenue of ₹25.52 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 252% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.3% | ||||
| Net Profit Margin | -12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tasyca Pharma Private Limited, buy the company report.
Board of directors of Tasyca Pharma Private Limited
Tasyca Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adarsh Narasimha Murthy | Director | 13 Nov 2013 | 13 Years 0 Months | Current |
| Anasuya Narsimha Murthy | Director | 13 Nov 2013 | 13 Years 0 Months | Current |
Peer comparison
Tasyca Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aras Remedies Private Limited | ₹25.63 Lakh (FY 2025) | 30.0% | Anand, Gujarat, India | |||
| Allzweck Life Sciences Private Limited | ₹25.58 Lakh (FY 2025) | -89.0% | New Delhi, Delhi, India | |||
| Tasyca Pharma Private Limitedthis company | ₹25.52 Lakh (FY 2025) | -₹3.19 Lakh | -12.5% | -30.0% | Bangalore, Karnataka, India | |
| Genotech Pharmaceuticals Private Limited | ₹25.44 Lakh (FY 2025) | -72.0% | Hyderabad, Telangana, India | |||
| Velox Lifesciences Private Limited | ₹25.27 Lakh (FY 2019) | 23.0% | Kalyan, Maharashtra, India |
To see the full peer comparison of Tasyca Pharma Private Limited, buy the company report.
Auditor
Tasyca Pharma Private Limited is audited by Bharathi.K.M for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bharathi.K.M | FY 2017 | 227079 |
Shareholding
The shareholding of Tasyca Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Tasyca Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tasyca Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tasyca Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tasyca Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECT8229K1ZR | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tasyca Pharma Private Limited, buy the company report.
Recent activity
Tasyca Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Adarsh Narasimha Murthy was appointed as Director on 13 Nov 2013.
Frequently asked questions
Tasyca Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 November 2013 (13+ years old) and is registered under CIN U24232KA2013PTC071840.
Tasyca Pharma has 2 current directors:
- Adarsh Narasimha Murthy - Director
- Anasuya Narsimha Murthy - Director
The latest financial statements of Tasyca Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Tasyca Pharma is 29AAECT8229K1ZR, registered in Karnataka.
The CIN (Corporate Identification Number) of Tasyca Pharma is U24232KA2013PTC071840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tasyca Pharma was incorporated on 13 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Tasyca Pharma by revenue are Aras Remedies Private Limited, Allzweck Life Sciences Private Limited, Genotech Pharmaceuticals Private Limited, Velox Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Adarsh Narasimha Murthy was appointed as Director on 13 Nov 2013. Anasuya Narsimha Murthy was appointed as Director on 13 Nov 2013.
The registered office of Tasyca Pharma is at Thammaiah #1532A 80 Feet Ring Road Nagadevanahalli, Bangalore, Karnataka, India – 560056.
Tasyca Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Tasyca Pharma is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.

